In a report released today, Matt Hewitt from Craig-Hallum maintained a Hold rating on Agiliti (AGTI – Research Report). The company’s shares closed yesterday at $9.91.
Hewitt covers the Healthcare sector, focusing on stocks such as Codexis, Avid Bioservices, and Schrodinger. According to TipRanks, Hewitt has an average return of 3.6% and a 48.69% success rate on recommended stocks.
The word on The Street in general, suggests a Hold analyst consensus rating for Agiliti with a $10.00 average price target, which is a 0.91% upside from current levels. In a report released yesterday, UBS also downgraded the stock to a Hold with a $10.00 price target.
See the top stocks recommended by analysts >>
Based on Agiliti’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $291.63 million and a GAAP net loss of $12.7 million. In comparison, last year the company earned a revenue of $271.19 million and had a net profit of $1.95 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Agiliti (AGTI) Company Description:
Agiliti, Inc. provides end-to-end healthcare technology management and service solutions to the United States healthcare industry. It also offers customers with access to quality healthcare technology and implement comprehensive medical equipment management and service solutions to reduce capital and operating expenses, increase medical equipment and staff productivity and support improved patient safety and outcomes. The company was founded in 1939 and is headquartered in Minneapolis, MN.
Read More on AGTI:
